News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media
Siteman Cancer Center benefits from QVC Presents “FFANY Shoes on Sale”
QVC and FFANY present a contribution of $300,000 as a result of charitable multiplatform event For more than 20 years, QVC Presents “FFANY Shoes on Sale” has combined great shopping with an even better cause. Last October during the annual charitable shoe sale, more than 80,000 pairs of shoes were purchased at half the manufacturer’s […]
Research
Even with genetic predisposition for lung cancer, quitting smoking reduces risk
Quitting smoking improves health and lowers odds of developing lung cancer. But a new study shows that even among smokers with a genetic predisposition to smoking heavily and developing lung cancer at a young age, the benefits of quitting are significant. An international study led by researchers at Washington University School of Medicine in St. […]
Prevention
Excess weight linked to 8 more cancer types
There’s yet another reason to maintain a healthy weight as we age. An international team of researchers has identified eight additional types of cancer linked to excess weight and obesity: stomach, liver, gall bladder, pancreas, ovary, meningioma (a type of brain tumor), thyroid cancer and the blood cancer multiple myeloma. Limiting weight gain over the […]
Research
$10.4 million awarded for pancreatic cancer research
The National Cancer Institute (NCI) has awarded a $10.4 million, five-year grant to Washington University researchers and physicians at Siteman Cancer Center to lead a national group of experts in collaborative pancreatic cancer research. The award, a prestigious Specialized Program of Research Excellence (SPORE) grant, will help scientists pursue new treatments for the deadliest form […]
Research
New study shows breast tumors evolve in response to hormone therapy
Many breast tumors grow in response to female hormones, especially estrogen. Drugs that reduce estrogen levels in the body often are effective in reducing tumor size and preventing recurrence of the cancer. But some tumors become resistant to these therapies and continue to grow and spread. A new analysis of breast tumors, before and after […]
Research
Study finds marker of aggressive prostate cancer
The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread, according to new research from Washington University School of Medicine in St. Louis. The study, available online in the journal European Urology, may inform future clinical tests that help doctors decide how […]
Research
Study aims to find clues to breast cancer outcomes in African-American women
Scientists’ understanding of the genetic roots of breast cancer is based largely on research conducted in women of European ancestry. That knowledge does little to help explain why African-American women with the disease are more likely to be diagnosed at younger ages and with more aggressive tumors than their white counterparts. They also die of […]
In the Media, Research
Potential drug target identified for deadly brain cancer
Glioblastoma is the most common and deadly form of brain cancer in adults, with an average survival time of only 15 months after diagnosis. New research at Washington University School of Medicine in St. Louis provides clues to why some patients with glioblastoma fare worse and identifies a drug target that potentially could improve survival. […]
Staff/Faculty Update
Sasa Mutic honored as innovator
Celebrating innovation in St. Louis, the St. Louis Business Journal on June 23 honored area individuals and companies with the publication’s third annual Innovation Awards. Among those honored were Sasa Mutic, PhD, director of the Medical Physics Division in the Department of Radiation Oncology at Washington University School of Medicine. He also is a Siteman […]
Research
Tissue Procurement Core receives accreditation
The Washington University Tissue Procurement Core, which offers researchers a centralized laboratory to collect, store and use human biospecimens for translational cancer research, has received accreditation by the College of American Pathologists (CAP). The recognition is based on a recent onsite inspection, designed to ensure the highest standards for laboratory operations. “We work hand in […]